The Vietnam Health Insurance market was valued at USD 11.23 Billion in 2024 and is expected to grow to USD 19.67 Billion by 2030 with a CAGR of 8.23%.

The Vietnam health insurance market was valued at USD 1.92 Billion in 2024, driven by rising government initiatives, expanding insurance coverage, and increased investment in healthcare services across the region. The market is anticipated to grow at a CAGR of 6.90% during the forecast period of 2025-2034 to achieve a value of USD 3.74 Billion by 2034.

Key Market Trends and Insights

• Based on market share by coverage, term insurance is expected to lead in the forecast period.
• For the market segmentation by distribution channel, direct sales are expected to witness a CAGR of 8.1% during the forecast period.
• Public providers are estimated to hold a notable market share in the coming years.

Market Size and Forecast

• Market Size (2024): USD 1.92 Billion
• Projected Market Size (2034): USD 3.74 Billion
• CAGR (2025-2034): 6.90%

In Vietnam Automation Sensors Market, was valued at approximately USD 10.11 billion in 2022 and is projected to reach USD 12.45 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 8.65% during the forecast period.

In 2023, Prudential had a new business premium income market share of almost ** percent, followed by Daiichi with a **** percent market share. Meanwhile, the Vietnamese state-owned enterprise Bao Viet Life ranked third with around ** percent of the total market share. In that year, the penetration rate of life insurance was at *** percent in the country.Bao Viet HoldingsBao Viet Holdings is among the prominent insurance companies in Vietnam. The state-owned firm has various subsidiaries including Bao Viet Insurance, Bao Viet Life, Bao Viet Fund, Bao Viet Securities, Bao Viet Bank, and Bao Viet Investment. In 2023, non-life gross written insurance premiums of Bao Viet amounted to over **** trillion Vietnamese dong, while life gross written insurance premiums reached about **** trillion Vietnamese dong.Life insurance in VietnamThe number of new life insurance policies has seen double-digit growth in recent years. In 2023, life gross written insurance premiums recorded about *** trillion Vietnamese dong. Life insurance categories include investment-linked policies, endowment insurance, term life insurance, annuity insurance, healthcare insurance, pension insurance, and whole life insurance. The market leaders for life insurance business based on insurance premiums were Bao Viet Life, Manulife, Prudential, and Dai-ichi.

In 2022, health insurance accounted for approximately **** percent of the gross premiums of non-life insurance sector in Vietnam. This was followed by automobile insurance, and property and casualty insurance, with around **** percent and **** percent of the gross premiums of non-life insurance market, respectively.

The Vietnam travel insurance market was estimated to attain a value of USD 112.77 Million in 2024 and is projected to expand at a CAGR of around 17.30% through 2034. A significant factor driving the Vietnam travel insurance market is the rising demand from digital nomads seeking motorbike accident coverage. As remote workers tour the country via scooters, policies with explicit "Adventure Sports" or motorbike protection, coupled with direct billing at top private hospitals, are gaining strong traction. This in turn is greatly contributing to the Vietnam travel insurance market growth, thus propelling the market to attain USD 556.13 Million by 2034.

Another factor pushing demand in the Vietnam travel insurance market is the rise in policies covering natural disaster-related trip cancellations and evacuations. In Q4 2024, insurers introduced specialized products after Typhoon Yagi caused over USD 80 million in damage, prompting PVI Insurance and others to develop add-ons for storm and flood disruptions. This trend reflects growing traveller concern and insurer innovation, offering protection not only for medical emergencies but also for weather-induced itinerary changes, thus addressing real risks in a typhoon-prone destination.

In December 2024, Tune Protect and AirAsia launched the AirAsia Comprehensive Travel PLUS insurance in Vietnam, featuring cashless hospital admissions for travellers departing Vietnam at no extra cost, and access to 7,500+ global hospitals. This game-changing feature significantly enhances traveller confidence by eliminating upfront medical expenses abroad and simplifying claims through in-app coordination with medical providers, tailored to the needs of international tourists and digital nomads., thus boosting the growth of the Vietnam travel insurance market. It signals a broader shift in Vietnam's travel insurance market towards frictionless healthcare support, embedding real-time assistance directly into travel experiences.

The Vietnam life insurance market was valued at USD 6.58 Billion in 2024. The industry is expected to grow at a CAGR of 6.30% during the forecast period of 2025-2034. Increasing urbanization has led to the surging demands for life insurance policies with consumers increasingly seeking financial security, retirement planning, and health protection amid increasing living expenses and lifestyle-related risks. In turn, all these factors have resulted in the market attaining a valuation of USD 12.12 Billion by 2034.

In 2023, health insurance recorded the highest value of gross premiums of non-life insurance in Vietnam, reaching over **** trillion Vietnamese dong (VND). In that year, the gross premiums for automobile insurance in the country amounted to around **** trillion VND, following by fire and explosion insurance with over *** trillion VND value of gross premiums. Automobile insurance in Vietnam In 2022, Vietnam experienced a significant surge in vehicle sales. As a result, the country is expected to see a consistent annual growth in the number of cars in use per 1,000 inhabitants. For car owners in Vietnam, civil liability insurance is compulsory. This insurance bears liability for any third party that suffered from damage caused by the insured car. In addition to that, car owners can voluntarily take out comprehensive car insurance which covers physical damage to the car. Non-life insurance in Vietnam The gross written premiums of the non-life insurance segment in the country amounted to over ** trillion VND in 2023. The market leaders, also referred to as the “big 5” of non-life insurance, included PVI, Bao Viet, PTI, Bao Minh, and Pjico. Compared to the previous year, business interruption insurance, fire and explosion insurance, health insurance, guarantee insurance, credit and financial risk insurance, hull and P&I insurance, cargo insurance, as well as automobile insurance had the highest growth rates within the non-life insurance sector.

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Vietnam”. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts. In 2015, Vietnam’s population stood at 92 million, an increase from 85 million in 2008 due to the high birth rate and low mortality rate. The country’s pharmaceutical market was estimated to have been worth $3.5 billion in 2015 and is expected to reach $6.6 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.8%. The medical device market was estimated at approximately $295m in 2015 and is expected to grow at a CAGR of 11.3% to $505m by 2020. The positive trends in Vietnam’s healthcare market can primarily be attributed to: Increasing coverage of healthcare insurance Government initiatives to improve healthcare facilities Read More

The Vietnam revenue cycle management market size is projected to exhibit a growth rate (CAGR) of 8.3% during 2025-2033. The increasing digital transformation in the healthcare industry, the rising medical tourism in the country, and the growing promotion of health insurance coverage by governing authorities represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on type, component, deployment mode, and end user.

Comprehensive dataset of 1 Health insurance agencies in Quảng Ninh, Vietnam as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Vietnam Fintech Market size was valued at USD 21.5 Billion in 2024 and is projected to reach USD 70.4 Billion by 2032, growing at a CAGR of 16% during the forecast period 2025 to 2032. Vietnam Fintech Market: Definition/Overview

Fintech in Vietnam is the integration of technology into financial services to improve efficiency, accessibility, and security. It includes a variety of digital solutions, such as mobile payments, digital banking, peer-to-peer (P2P) financing, blockchain-based transactions, and rob o-advisory services. The growing use of e-wallets, online payment gateways, and alternative financing platforms has altered financial transactions, making them more frictionless and inclusive, especially for the unbanked population.

Vietnam's fintech is expected to grow rapidly, owing to rising internet penetration, government backing for cashless payments, and rising consumer demand for digital financial services.

Comprehensive dataset of 1 Health insurance agencies in District 4, Ho Chi Minh City, Vietnam as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

The Vietnamese diabetes care devices market, valued at $424.10 million in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 2.10% from 2025 to 2033. This relatively modest growth, compared to other global markets, reflects a confluence of factors. Key drivers include the rising prevalence of diabetes in Vietnam, fueled by an aging population, increasing urbanization, and lifestyle changes contributing to higher rates of obesity and sedentary behavior. The growing awareness of diabetes management and the increasing availability of advanced devices like continuous glucose monitors (CGMs) are also contributing positively. However, several trends are shaping the market's trajectory. The increasing adoption of telemedicine and remote patient monitoring solutions presents a significant opportunity for growth, particularly in improving access to care in rural areas. Furthermore, a growing preference for user-friendly and technologically advanced devices, coupled with the rising affordability of these technologies, is stimulating market expansion. Conversely, restraining factors include high costs associated with certain devices, particularly CGMs and insulin pumps, which limit accessibility for a large segment of the population. Furthermore, the healthcare infrastructure in Vietnam, while improving, still faces challenges in terms of capacity and affordability, potentially hindering wider adoption of these technologies. The market is segmented into monitoring devices (self-monitoring blood glucose devices, including glucometers, test strips, and lancets; and continuous glucose monitoring systems) and management devices (insulin pumps, insulin syringes, insulin cartridges, and disposable pens). Major players like Roche, Abbott, Medtronic, Novo Nordisk, and Johnson & Johnson (Lifescan) are actively competing in this market, vying for market share through product innovation, distribution networks, and strategic partnerships. The competitive landscape is dynamic, with both multinational corporations and potentially local players vying for market share. While multinational companies dominate the higher-end segments with advanced technologies, local players might focus on more affordable options to cater to the price-sensitive market. Future growth hinges on several factors, including government initiatives to improve healthcare access and affordability, the development of innovative, cost-effective diabetes management solutions specifically tailored to the Vietnamese market, and the continued expansion of health insurance coverage. Further research into the specific regional variations within Vietnam, considering factors like income levels and healthcare infrastructure in different provinces, would provide a more granular understanding of market potential. The success of companies in the Vietnamese market will depend on their ability to adapt to local needs and preferences, develop effective distribution strategies, and engage effectively with healthcare professionals and patients alike. Addressing affordability concerns remains crucial for achieving significant market penetration and ensuring wider access to effective diabetes management solutions for the growing diabetic population in Vietnam. Recent developments include: May 2023: The VPA and Roche Diabetes Care Vietnam, represented by Roche Vietnam Company Limited, have partnered to improve healthcare access for disadvantaged children with Type 1 diabetes in Vietnam as part of the global initiative CDiC. Led by Novo Nordisk and Roche Diabetes Care, this program aims to expand healthcare access and provide insulin and supplies to children and young individuals with Type 1 diabetes up to age 25 in countries with limited resources., January 2022: With a grant of DKK 5 million from the Danish Ministry of Foreign Affairs, the project 'Gestational Diabetes in Vietnam' will, in close collaboration with local researchers and health care workers, investigate GDM in Vietnam's northern Thai Binh province. GDM is estimated to affect about one in five pregnant women in Vietnam, but little is known about how it is handled by pregnant women, families, and healthcare providers., March 2021: Abbott Vietnam has introduced the FreeStyle Libre system, the world's leading glucose monitoring technology, for people with diabetes in Việt Nam.. Key drivers for this market are: Increasing Number of Preterm and Low-weight Births, Advanced Technology in Fetal and Prenatal Monitoring. Potential restraints include: Stringent Regulatory Procedures. Notable trends are: Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market.

Comprehensive dataset of 1 Health insurance agencies in Quỳnh Lưu District, Nghe An, Vietnam as of August, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset of 2 Health insurance agencies in Lâm Hà District, Lam Dong, Vietnam as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

The global diabetes care devices market, valued at $424.10 million in 2025 and exhibiting a 2.10% CAGR, presents significant opportunities within Vietnam. While precise Vietnamese market data is unavailable, we can extrapolate reasonable estimates based on global trends and regional economic factors. Considering Vietnam's growing population, rising diabetes prevalence mirroring global increases, and increasing healthcare expenditure, the Vietnamese market is likely experiencing substantial growth, although at a rate potentially slightly below the global average due to factors such as lower per capita income compared to developed nations. The market is segmented into monitoring and management devices. Monitoring devices, including self-monitoring blood glucose (SMBG) devices (glucometers, test strips, lancets) and continuous glucose monitoring (CGM) systems (sensors and durables), are likely experiencing rapid adoption driven by increased awareness and convenience. Management devices, such as insulin pumps, syringes, cartridges, and disposable pens, are also witnessing growth, albeit potentially at a slower pace due to higher costs and the need for medical expertise. Key drivers include increased diabetes diagnosis rates, government initiatives to improve healthcare access, and rising disposable incomes within Vietnam's expanding middle class. However, constraints may include affordability issues for certain technologies, particularly in rural areas, and a need for improved patient education and healthcare infrastructure. Major global players like Becton Dickinson, Medtronic, and Abbott are likely present in the Vietnamese market either directly or through distributors, contributing to competition and technological advancements. Future growth will depend on the success of government initiatives aimed at tackling diabetes prevalence, increasing insurance coverage, and raising public awareness. The competitive landscape within Vietnam likely reflects a mix of international and local players. While specific market share data for Vietnam is unavailable, it's likely that multinational corporations hold a significant share due to their established brand recognition and advanced technologies. However, local players may gain traction by offering more affordable solutions tailored to the specific needs of the Vietnamese population. Growth is expected to be driven by the increasing availability of affordable SMBG devices and government programs promoting early diagnosis and disease management. The expansion of CGM technology, while facing challenges related to cost and infrastructure, holds significant potential for future market expansion in Vietnam. Further market segmentation analysis would require specific Vietnamese market research data, but the existing global data provides a solid foundation for understanding the key dynamics at play. Recent developments include: May 2023: The VPA and Roche Diabetes Care Vietnam, represented by Roche Vietnam Company Limited, have partnered to improve healthcare access for disadvantaged children with Type 1 diabetes in Vietnam as part of the global initiative CDiC. Led by Novo Nordisk and Roche Diabetes Care, this program aims to expand healthcare access and provide insulin and supplies to children and young individuals with Type 1 diabetes up to age 25 in countries with limited resources., January 2022: With a grant of DKK 5 million from the Danish Ministry of Foreign Affairs, the project 'Gestational Diabetes in Vietnam' will, in close collaboration with local researchers and health care workers, investigate GDM in Vietnam's northern Thai Binh province. GDM is estimated to affect about one in five pregnant women in Vietnam, but little is known about how it is handled by pregnant women, families, and healthcare providers., March 2021: Abbott Vietnam has introduced the FreeStyle Libre system, the world's leading glucose monitoring technology, for people with diabetes in Việt Nam.. Notable trends are: Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market.

The Vietnam insulin infusion pump market, valued at $1.14 billion in 2025, is projected to experience robust growth, driven by rising diabetes prevalence, increasing awareness of advanced diabetes management technologies, and government initiatives promoting better healthcare access. The Compound Annual Growth Rate (CAGR) of 5.04% from 2025 to 2033 indicates a steady expansion, with significant potential for market players. Key market segments include insulin pump devices, infusion sets, and reservoirs, each contributing to the overall market growth. The increasing adoption of continuous glucose monitoring (CGM) systems alongside insulin pumps is a major trend, enhancing patient convenience and improving glycemic control. However, high initial costs associated with insulin pumps and limited healthcare insurance coverage represent significant market restraints. Competition among major players like Medtronic, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care is intensifying, with companies focusing on product innovation, technological advancements, and strategic partnerships to gain market share. The market's future success hinges on addressing affordability concerns, improving access to advanced technologies in rural areas, and providing comprehensive diabetes education to promote informed treatment decisions. The growth trajectory of the Vietnamese insulin infusion pump market is expected to accelerate in the coming years, fueled by a growing diabetic population and improved healthcare infrastructure. Technological advancements, such as the development of smaller, more user-friendly pumps and integrated CGM systems, are further contributing to market expansion. However, challenges persist. The need for greater affordability and wider healthcare insurance coverage remains a critical factor impacting market penetration. Government initiatives to improve diabetes care and increase public awareness about the benefits of insulin infusion pumps will be crucial in driving market growth. Further research into cost-effective solutions and strategic partnerships between healthcare providers and technology companies will be vital for making insulin infusion pumps more accessible to the growing number of individuals living with diabetes in Vietnam. Recent developments include: May 2023: The United States Food and Drug Administration (FDA) cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type-1 diabetes. These two devices and a compatible FDA-cleared integrated continuous glucose monitor (iCGM) will form a new system called the iLet Bionic Pancreas. This new automated insulin dosing (AID) system uses an algorithm to determine and command insulin delivery., March 2023: Defense Health Agency (DHA) officials announced that military family members who have type-1 diabetes can now get Tricare coverage for the Omnipod 5 insulin pump.. Notable trends are: Insulin Pump is Expected to Witness Growth Over the Forecast Period.

Comprehensive dataset of 1 Health insurance agencies in Tấm Kỳ, Quảng Nam, Vietnam as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

The size of the Vietnam Insulin Infusion Pump market was valued at USD 1.14 Million in 2023 and is projected to reach USD 1.61 Million by 2032, with an expected CAGR of 5.04% during the forecast period.An insulin infusion pump is a portable, computerized device that supplies immediate, measured quantities of insulin directly into the blood. It might well prove life-altering for patients with diabetes who are required to make multiple injections daily or for newly initiated patients on intensive therapy. The device will provide a constant basal dose of insulin and distribute the bolus doses at desired intervals to maintain the blood sugar level. Hence, it is more flexible and accurate than injections carried out through the conventional method. The rising prevalence of diabetes in the country may be associated with increased awareness about the sophisticated techniques of managing diabetes; this is one growth driver in the market for insulin infusion pumps. With the population ageing and factors of lifestyle changing towards more sedentary habits and unhealthy diets, it has been contributing to an increased prevalence of cases of diabetes in the country. It means this: there is an ever-increasing demand for effective and convenient systems of insulin delivery. Some of the benefits that the Vietnamese diabetic patients will benefit from the use of infusion pumps are control over blood glucose levels, fewer incidence of hypoglycemia, and general quality of life. Any person diagnosed with type 1 diabetes, pregnant woman suffering from gestational diabetes, or a patient who needs multiple daily injections will probably benefit from the use of these devices. High cost and low health care insurance coverage, lack of awareness about the benefits, from infusion pump to some other factors may limit the market growth. All these devices should be available to Vietnamese citizens through making the manufacturers and healthcare providers educate patients, affordability initiatives, and partnerships with insurance companies. Recent developments include: May 2023: The United States Food and Drug Administration (FDA) cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type-1 diabetes. These two devices and a compatible FDA-cleared integrated continuous glucose monitor (iCGM) will form a new system called the iLet Bionic Pancreas. This new automated insulin dosing (AID) system uses an algorithm to determine and command insulin delivery., March 2023: Defense Health Agency (DHA) officials announced that military family members who have type-1 diabetes can now get Tricare coverage for the Omnipod 5 insulin pump.. Key drivers for this market are: Increasing Applications of Cryosurgery, Technological Advancements in Cryotherapy Equipment; Rising Preference for Minimally Invasive Techniques. Potential restraints include: Hazardous Effects of Cryogenic Gases, Complexity of the Cryotherapy Mechanisms. Notable trends are: Insulin Pump is Expected to Witness Growth Over the Forecast Period.